Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

Pre-Stabilisation Period Notice

4 Nov 2021 07:00

RNS Number : 3387R
Merrill Lynch International
04 November 2021
 

 

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE UNLAWFUL

 

4 November 2021

Pod Point Group Holdings plc Pre-Stabilisation Period Notice

Merrill Lynch International hereby gives notice that it, and its affiliates, may stabilise the offer of the following securities in accordance with the relevant provisions of Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052, in each case as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018. Stabilisation transactions aim at supporting the market price of the Securities during the Stabilisation Period. Stabilisation may not necessarily occur and it may cease at any time.

 

 

Securities:

 

Issuer:

 

Pod Point Group Holdings plc (the "Issuer")

 

Securities to be stabilised:

 

Ordinary shares of £0.001 each in the capital of the Issuer (ISIN: GB00BNDRD100) (the "Shares")

 

Offering size:

 

44,315,828 Shares (excluding the over-allotment option)

 

Offer price:

 

225 pence per Share

 

Stabilisation:

 

Stabilisation

 

Merrill Lynch International, 2 King Edward Street, London, EC1A 1HQ

 

 

Manager:

Contact: Andrew Briscoe; Telephone: +44 207 995 3700

 

Stabilisation Period expected to start on:

 

4 November 2021

 

Stabilisation Period expected to end no later than:

 

3 December 2021

 

Stabilisation trading venue:

 

London Stock Exchange - Main Market

 

Maximum size and conditions of use of

over‑allotment facility:

 

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law, up to the maximum size of 4,431,583 Shares

 

Over-allotment Option:

 

Terms:

 

In connection with the offering (the "Offer"), Merrill Lynch International (as Stabilising Manager), or any of its agents, may (but will be under no obligation to), to the extent permitted by applicable law and for stabilisation purposes, over-allot Shares up to a total of 10% of the total number of Shares included in the Offer or effect other transactions with a view to supporting the market price of the Shares or any options, warrants or rights with respect thereto, or other interest in the Shares or other securities of the Company, in each case at a higher level than that which might otherwise prevail in the open market.

 

The Stabilising Manager is not required to enter into such transactions and such transactions may be effected on any securities market, over-the-counter market, stock exchange or otherwise and may be undertaken at any time during the period commencing on the date of the conditional dealings in the Shares on the London Stock Exchange and ending no later than 30 calendar days thereafter. Stabilisation transactions aim at supporting the market price of the securities during the stabilisation period. Such stabilisation, if commenced, may be discontinued at any time without prior notice. If such stabilisation occurs, it will be undertaken at the London Stock Exchange. However, there will be no obligation on the Stabilising Manager or any of its agents to effect stabilising transactions and there is no assurance that stabilising transactions will be undertaken. In no event will measures be taken to stabilise the market price of the Shares above the Offer Price. Except as required by law or regulation, neither the Stabilising Manager nor any of its agents intends to disclose the extent of any over-allotments made and/or stabilising transactions conducted in relation to the Offer.

 

For the purposes of allowing the Stabilising Manager to cover short positions resulting from any such over-allotment and/or from sales of Shares effected by it

 

 

 

during the stabilisation period, the Stabilising Manager has been granted an over- allotment option (the "Over-allotment Option"), pursuant to which it may purchase, or procure purchasers for, Shares (representing up to 10%) of the total number of Shares included in the Offer) at the Offer Price (the "Over-allotment Shares"). The Over-allotment Option may be exercised in whole or in part upon notice by the Stabilising Manager at any time on or before the 30th calendar day after the commencement of conditional dealings in the Shares on the London Stock Exchange. Any Over-allotment Shares made available pursuant to the Over- allotment Option will be made available on the same terms and conditions as Shares being offered or sold pursuant to the Offer, will rank pari passu in all respects with all other Shares (including with respect to pre-emption rights) and will form a single class with all other Shares for all purposes, including with respect to voting and for all dividends and distributions thereafter declared, made or paid on the ordinary share capital of the Company.

 

Duration:

 

The Over-allotment Option may be exercised in whole or in part at any time during the Stabilisation Period.

 

 

In connection with the offer of the above securities, the Stabilising Manager, or any of its agents, may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilising action, if begun, may cease at any time. Any stabilising action or over‑allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States of America (the "United States"), Australia, Canada, Japan or any other jurisdiction where such release, publication or distribution would be unlawful. This announcement does not contain or constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or any other jurisdiction where such an offer would be unlawful.

 

The securities discussed herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The securities may not be offered, sold, resold, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities discussed herein is being made in the United States. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada or Japan or to any national, resident or citizen of Australia, Canada or Japan. The release, publication or distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

 

This announcement is only addressed to and directed at specific addressees who: (A) if in member states of the European Economic Area (the "EEA"), are persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) ("Qualified Investors"); and (B) if in the United Kingdom, are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of retained EU law by virtue of the European Union (Withdrawal) Act 2018 who are: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities falling within Article 49(2) (a) to (d) of the Order; or (C) are other persons to whom it may otherwise lawfully be communicated (all such persons referred to in (B) and (C) together being "Relevant Persons"). This announcement must not be acted or relied on (i) in the United Kingdom, by persons who are not Relevant Persons and (ii) in any member state of the EEA by persons who are not Qualified Investors. Any investment activity to which this announcement relates (i) in the United Kingdom is available only to, and may be engaged in only with, Relevant Persons; and (ii) in any member state of the EEA is available only to, and may be engaged only with, Qualified Investors.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFIFSRLALSIIL
Date   Source Headline
2nd Jun 202511:07 amRNSTotal Voting Rights
2nd Jun 20258:02 amRNSDirector Declaration
22nd May 202510:17 amRNSExtension of PUSU Deadline & Timing of Results
22nd May 20257:00 amRNSLaunch of Pod Drive
15th May 20255:53 pmRNSM J Tilbrook-Form 8.3-Pod Point Group Holdings plc
9th May 20252:00 pmRNSDirector's Leave of Absence
8th May 20256:12 pmRNSForm 8.3 - Pod Point Group Holdings plc
8th May 202512:32 pmRNSForm 8 (OPD) Pod Point Group Holdings Plc
8th May 20257:00 amRNSForm 8 (OPD) - Pod Point Group Holdings Plc
1st May 202510:41 amRNSForm 8.5 (EPT/RI)
1st May 20257:30 amRNSSuspension - Pod Point Group Holdings plc
30th Apr 20259:56 amRNSForm 8.5 (EPT/RI)
29th Apr 202510:20 amRNSForm 8.5 (EPT/RI)
28th Apr 202511:41 amRNSForm 8.5 EPT/Non RI POD POINT GROUP HOLDINGS PLC
28th Apr 202510:45 amRNSForm 8.5 (EPT/RI) - Pod Point Group Holdings PLC
25th Apr 20253:14 pmRNSForm 8.3 - Pod Point Group Holdings plc
25th Apr 20251:38 pmPRNForm 8.3 - Pod Point Group Holdings PLC
25th Apr 20251:29 pmRNSForm 8.3 - POD POINT GROUP HOLDINGS PLC
25th Apr 202512:24 pmRNSForm 8.3 - Pod Point Group Holdings plc
25th Apr 202512:00 pmRNSForm 8.5 EPT/Non RI POD POINT GROUP HOLDINGS PLC
25th Apr 202510:24 amRNSForm 8.5 (EPT/RI)
24th Apr 20254:49 pmRNSRule 2.9 Announcement
24th Apr 20257:00 amRNSPossible Offer for Pod Point and Delayed Results
15th Apr 20257:00 amRNSFY2024 Update and Notice of Results
4th Apr 20259:00 amRNSMajor Shareholding Notification
1st Apr 202510:26 amRNSTotal Voting Rights
4th Mar 20257:00 amRNSDirectorate and Committee Change
29th Jan 20257:00 amRNSNew Energy Flex Market Entered
20th Jan 20257:00 amRNSTrading Update
24th Dec 20247:00 amRNSDirectorate Change
19th Dec 20247:00 amRNSKey Milestone For International Expansion
11th Dec 20249:55 amRNSBlock listing Interim Review
2nd Dec 202411:53 amRNSDirector/PDMR Shareholding
18th Nov 20247:00 amRNSNetwork Milestone Passed
9th Oct 20247:00 amRNSDirectorate Change
11th Sep 20247:00 amRNSEntry Into New Energy Flex Market
30th Jul 20247:00 amRNSHalf-year Report
26th Jul 20249:39 amRNSBoard Committee Changes
15th Jul 20247:00 amRNSNotice of Interim Results
10th Jul 20247:00 amRNSEnergy Flex Capital Market Event
26th Jun 20249:00 amRNSNotice of Flex Capital Market Event
24th Jun 20247:00 amRNSAppointment of Joint Corporate Broker
7th Jun 202411:58 amRNSBlock listing Interim Review
5th Jun 20243:25 pmRNSResult of AGM
3rd Jun 20248:40 amRNSMajor Shareholding Notification
31st May 202411:53 amRNSDirector/PDMR Shareholding
30th Apr 202411:00 amRNSTotal Voting Rights
26th Apr 20242:29 pmRNSAnnual Report & Notice of AGM
19th Apr 202411:32 amRNSDirector/PDMR Shareholding
18th Apr 20247:00 amRNSPreliminary Results for FY2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.